News & Articles

Results per page

Selected Filters:

Epigenetic Analysis Clear Filters

Editorial Article

ddPCR technology drives progress in oncology research

28 Aug 2024

Industry News

PharmaKure announces epigenetics collaboration with Sheffield Hallam University to understand mechanisms of Alzheimer’s diseases

4 Mar 2024

Product News

Tecan offers end-to-end solutions for cellomics

5 Feb 2024

Product News

PharmaKure and Universiti Teknologi MARA (UiTM) announce partnership to advance research in Alzheimer’s disease diagnosis

20 Dec 2023

Industry News

Epigenomics unlocks the potential of precision medicine

16 Oct 2023

Editorial Article

Protecting against human error: Why documentation and data are important

12 Jun 2023

Editorial Article

The top 10 products accelerating pharmacology

31 May 2023

Editorial Article

10 remarkable products accelerating science in the life sciences

31 May 2023

Editorial Article

Discover the latest news for analytica 2022 on SelectScience

20 Jun 2022

Editorial Article

Single-cell genomics at the Memorial Sloan Kettering Cancer Center: Developing innovative methods

2 May 2022

Industry News

Leukemia patients with certain gene regulation patterns may be less likely to respond to CAR T therapy

12 Apr 2022

Industry News

Shoots and roots respond differently to climate change

30 Dec 2021

Editorial Article

6 top reasons why scientists read reviews on SelectScience

6 Dec 2021

Industry News

Moderna edges out Pfizer vaccine in head-to-head comparison

3 Dec 2021

Editorial Article

How genome editing in iPSCs can reveal the intricacies of the human genome

30 Aug 2021

Industry News

ERS Genomics and Japan SLC sign CRISPR/Cas9 license agreement

28 Jul 2021

Industry News

Sherlock Biosciences announces initial results of automation study with NorDx Laboratories on CRISPR-based test for SARS-CoV-2

26 Jul 2021

Industry News

binx health submits request for Emergency Use Authorization for first CRISPR-based point-of-care test for COVID-19

17 May 2021

Editorial Article

Access your free cancer and immunology resources ahead of the virtual summit

16 May 2021

Industry News

An on-off switch for gene editing

29 Apr 2021

Editorial Article

Virtual Cancer and Immunology Research Summit 2021: Full meeting agenda

19 Apr 2021

Product News

IDT launches rhAmpSeq™ CRISPR analysis system

28 Mar 2021

Industry News

Novel pooled testing strategies can significantly increase ability to identify COVID-19 infections

25 Feb 2021

Industry News

Orgenesis, Cure Therapeutics to advance point-of-care development and commercialization of cell and gene therapies

11 Dec 2020

Editorial Article

Virtual Neuroscience Summit: Registration now open

21 Oct 2020

News & Articles

Articles Filter

Search

Selected Filters:

ddPCR technology drives progress in oncology research

PharmaKure announces epigenetics collaboration with Sheffield Hallam University to understand mechanisms of Alzheimer’s diseases

Tecan offers end-to-end solutions for cellomics

PharmaKure and Universiti Teknologi MARA (UiTM) announce partnership to advance research in Alzheimer’s disease diagnosis

Epigenomics unlocks the potential of precision medicine

Protecting against human error: Why documentation and data are important

The top 10 products accelerating pharmacology

10 remarkable products accelerating science in the life sciences

Discover the latest news for analytica 2022 on SelectScience

Single-cell genomics at the Memorial Sloan Kettering Cancer Center: Developing innovative methods

Leukemia patients with certain gene regulation patterns may be less likely to respond to CAR T therapy

Shoots and roots respond differently to climate change

6 top reasons why scientists read reviews on SelectScience

Moderna edges out Pfizer vaccine in head-to-head comparison

How genome editing in iPSCs can reveal the intricacies of the human genome

ERS Genomics and Japan SLC sign CRISPR/Cas9 license agreement

Sherlock Biosciences announces initial results of automation study with NorDx Laboratories on CRISPR-based test for SARS-CoV-2

binx health submits request for Emergency Use Authorization for first CRISPR-based point-of-care test for COVID-19

Access your free cancer and immunology resources ahead of the virtual summit

An on-off switch for gene editing

Virtual Cancer and Immunology Research Summit 2021: Full meeting agenda

IDT launches rhAmpSeq™ CRISPR analysis system

Novel pooled testing strategies can significantly increase ability to identify COVID-19 infections

Orgenesis, Cure Therapeutics to advance point-of-care development and commercialization of cell and gene therapies

Virtual Neuroscience Summit: Registration now open

News & Articles

Articles FilterArticles Filter

Search

Selected Filters:

ddPCR technology drives progress in oncology research

PharmaKure announces epigenetics collaboration with Sheffield Hallam University to understand mechanisms of Alzheimer’s diseases

Tecan offers end-to-end solutions for cellomics

PharmaKure and Universiti Teknologi MARA (UiTM) announce partnership to advance research in Alzheimer’s disease diagnosis

Epigenomics unlocks the potential of precision medicine

Protecting against human error: Why documentation and data are important

The top 10 products accelerating pharmacology

10 remarkable products accelerating science in the life sciences

Discover the latest news for analytica 2022 on SelectScience

Single-cell genomics at the Memorial Sloan Kettering Cancer Center: Developing innovative methods

Leukemia patients with certain gene regulation patterns may be less likely to respond to CAR T therapy

Shoots and roots respond differently to climate change

6 top reasons why scientists read reviews on SelectScience

Moderna edges out Pfizer vaccine in head-to-head comparison

How genome editing in iPSCs can reveal the intricacies of the human genome

ERS Genomics and Japan SLC sign CRISPR/Cas9 license agreement

Sherlock Biosciences announces initial results of automation study with NorDx Laboratories on CRISPR-based test for SARS-CoV-2

binx health submits request for Emergency Use Authorization for first CRISPR-based point-of-care test for COVID-19

Access your free cancer and immunology resources ahead of the virtual summit

An on-off switch for gene editing

Virtual Cancer and Immunology Research Summit 2021: Full meeting agenda

IDT launches rhAmpSeq™ CRISPR analysis system

Novel pooled testing strategies can significantly increase ability to identify COVID-19 infections

Orgenesis, Cure Therapeutics to advance point-of-care development and commercialization of cell and gene therapies

Virtual Neuroscience Summit: Registration now open

Articles Filter